This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Soligenix, Inc., Inimex Pharmaceuticals Inc.. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2016
Title: Innovations by Shannon Wayne Lentz: Advancements in Immune Modulation
Introduction: Shannon Wayne Lentz, an inventive mind based in Vancouver, CA, has significantly contributed to the scientific community through his innovative work in the field of immunology. With a total of three patents to his name, Lentz is focused on developing novel solutions for treating and preventing immune-related disorders, showcasing the potential of peptides in modulating innate immunity.
Latest Patents: Lentz's latest patent involves the creation of isolated novel peptides aimed at treating and preventing immune-related disorders. These peptides are designed to modulate innate immunity in subjects, offering a new approach to fend off infections. The invention encompasses not only the peptides themselves but also includes reactive agents, pharmaceutical compositions, and methods for producing these peptides using recombinant nucleic acids. Additionally, it introduces techniques for predicting a subject's responsiveness to the treatments involving these peptides, further enhancing therapeutic precision.
Career Highlights: Over the years, Lentz has been associated with notable companies that have bolstered his research efforts. He has worked at Soligenix, Inc., where his expertise likely contributed to advancements in therapeutic development. Additionally, he has been affiliated with Inimex Pharmaceuticals Inc., allowing him to collaborate on innovative projects that intersect with his passion for immunology.
Collaborations: Throughout his career, Lentz has collaborated with distinguished professionals, including Oreola Donini and Annett Rozek. These partnerships have not only expanded his research capabilities but also fostered an environment of innovation and knowledge exchange within the scientific community.
Conclusion: Shannon Wayne Lentz exemplifies the spirit of innovation in the realm of immunology. His contributions through patenting novel peptides to modulate innate immunity highlight his commitment to addressing immune-related disorders. Lentz's work, coupled with strategic collaborations and experiences in reputable companies, positions him as a notable inventor in the field, paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile